Continuous Renal Replacement Therapy (CRRT) Market by Product (Systems, Disposables, & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022

  • ID: 4337642
  • Report
  • Region: Asia Pacific, Europe, North America, United States
  • 189 Pages
  • Markets and Markets
1 of 6
The Global CRRT Market is Projected to Reach USD 1.53 Billion By 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%

FEATURED COMPANIES

  • B. Braun Melsungen Ag
  • Bellco S.R.L. (Italy)
  • Cytopherx, Inc. (U.S.)
  • Medica S.P.A.
  • Medtronic Plc
  • Nipro Corporation (Japan)
  • MORE

“CRRT market projected to grow at a CAGR of 7.0%”

The global CRRT market is projected to reach USD 1.53 billion by 2022 from USD 1.09 billion in 2017, at a CAGR of 7.0%. Increasing global incidence of acute kidney injury, growing number of ICU patients, increasing incidence of sepsis, and tehcnologcal advancements are some of the factors driving the growth of the CRRT market. However, high procedural cost of CRRT and stringent regulatory guidelines for CRRT in North America are expected to hinder market growth.

“Hemofilters to form the largest segment of CRRT disposables as of 2017”

On the basis of product, CRRT disposables segment is further sub-segmented to the bloodline sets, hemofilters, and other disposables (such as vascular access catheters and CRRT accessories, including drainage bags, ancillaries, stop cocks, syringes, and priming solutions). The hemofilters segment is estimated to account for the largest share of the disposables market due to the development of novel hemofilters and their increasing use in CRRT procedures.

“Continuous Venovenous Hemofiltration (CVVH) modality segment expected to be the largest segment during 2017-2022”

Based on modality, the CRRT market is segmented into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). The The CVVH modality is estimated to account for the largest share of the global CRRT market owing to the wide adoption of this modality among healthcare providers.

“Asia-Pacific is expected to register the highest growth rate in the CRRT market”

Geographically, the CRRT market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific is expected to register the highest growth rate during the forecast period, owing to the large acute kidney injury patient population, high utilization of CRRT in Australia and Japan, and improving healthcare infrastructure across Asian countries.

Breakdown of supply-side primary interviews:

  • By Company Type - Tier 1 – 40%, Tier 2 – 25%, and Tier 3 – 35%
  • By Designation – C level – 26%, Director level – 30%, and Others – 44%
  • By Region – North America - 34%, Europe – 26%, APAC – 23%, and RoW – 17%

The major players in the market are Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Infomed SA (Switzerland), and Medica S.p.A. (Italy), and Toray Medical Co., Ltd. (Japan).

Research Coverage

This report studies the CRRT market based on product and modality. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and prospects in the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the CRRT market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the recommended strategies for strengthening their market shares.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • B. Braun Melsungen Ag
  • Bellco S.R.L. (Italy)
  • Cytopherx, Inc. (U.S.)
  • Medica S.P.A.
  • Medtronic Plc
  • Nipro Corporation (Japan)
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Approach
2.2 Secondary And Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data from Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data from Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation And Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Crrt: Market Overview (2017)
4.2 Global Crrt Market, By Product, 2017 Vs. 2022
4.3 Crrt Market, By Modality And Region (2017)
4.4 Geographic Snapshot: Crrt Market (2017)

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Global Incidence of Aki
5.2.1.2 Growing Number of Icu Patients
5.2.1.3 Clinical Advantages of Crrt Over Intermittent Blood Purification Techniques
5.2.1.4 Technological Advancements And New Product Launches
5.2.1.5 Increasing Incidence of Sepsis
5.2.1.6 Growing Prevalence of Diabetes And Hypertension
5.2.2 Restraints
5.2.2.1 High Procedural Cost of Crrt
5.2.2.2 Stringent Regulatory Guidelines for Crrt in North America
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Increasing Applications of Crrt
5.2.3.2.1 Evolution of Crrt from a Simple Renal Replacement Treatment to a Multi-Organ Support Therapy (Most)
5.2.3.2.2 Progression of Crrt from Adaptive Renal Devices to Multipurpose Treatment Machines
5.2.3.3 Ongoing Research to Establish the Safety And Efficacy Profile of Crrt
5.2.3.4 Development of a Crrt System for Pediatric Patients
5.2.3.4.1 the Carpediem Project
5.2.3.5 Untapped Market Growth Opportunities in North America
5.2.4 Challenges
5.2.4.1 High Complexity of the Therapy
5.2.4.1.1 Lack of Standard Treatment Guidelines in Developing Countries
5.2.4.1.2 Complications Associated With Crrt
5.2.4.2 Shortage of Trained Icu Nurses in Developed Countries
5.2.4.3 Poor Reimbursement Scenario in Developing Countries
5.2.4.4 Lack of Awareness About the Benefits of Crrt

6 Industry Insights
6.1 Introduction
6.2 Reimbursement Scenario
6.2.1 North America
6.2.2 Europe
6.2.3 Asia-Pacific (Excluding Japan)
6.2.4 Japan
6.2.5 Rest of the World
6.3 Regulatory Landscape
6.3.1 North America
6.3.2 Europe
6.3.3 Asia-Pacific
6.3.4 Rest of the World
6.3.5 Industry Trends
6.3.5.1 Training Programs for the Operation of Crrt Devices
6.3.5.2 Rising Adoption of User-Friendly Crrt Machines
6.3.5.3 Development of a Crrt System for Pediatric Patients
6.4 Porter’S Five Forces Analysis
6.4.1 Competitive Intensity
6.4.2 Bargaining Power of Buyers
6.4.3 Bargaining Power of Suppliers
6.4.4 Threat of Substitutes
6.4.5 Threat of New Entrants
6.5 Pricing And Cost Analysis
6.6 Strategic Recommendations
6.6.1 Design Recommendations
6.6.2 Key Strategies for Players Seeking to Enter the Crrt Market

7 Adoption of Continuous Renal Replacement Therapy, By Region
7.1 Introduction
7.2 Utilization of Crrt Procedures, By Region
7.3 Number of Crrt Patients, By Region

8 Continuous Renal Replacement Therapy Market, By Product
8.1 Introduction
8.1.1 Dialysates And Replacement Fluids
8.1.2 Disposables
8.1.2.1 Hemofilters
8.1.2.2 Bloodline Sets (Tubing Sets)
8.1.2.3 Other Disposables
8.1.3 Systems

9 Continuous Renal Replacement Therapy Market, By Modality
9.1 Introduction
9.2 Continuous Venovenous Hemofiltration (Cvvh)
9.3 Continuous Venovenous Hemodiafiltration (Cvvhdf)
9.4 Continuous Venovenous Hemodialysis (Cvvhd)
9.5 Slow Continuous Ultrafiltration (Scuf)

10 Continuous Renal Replacement Therapy Market, By Region
10.1 Introduction
10.2 Europe
10.2.1 Approval of Crrt Machines for Multiple Applications
10.2.2 Intensivist Preference for Crrt for Aki Treatment
10.2.3 Players Focus On Leveraging Growth Opportunities in Europe
10.2.4 Germany
10.2.4.1 Rising Focus of Players On the German Crrt Market
10.2.4.2 Favorable Reimbursement for Crrt
10.2.5 U.K.
10.2.5.1 Rising Awareness About Aki in the U.K.
10.2.6 France
10.2.6.1 Significant Number of Ongoing Clinical Studies
10.2.7 Rest of Europe
10.3 North America
10.3.1 High Preference for Other Dialysis Modalities
10.3.2 Regulatory Policies, a Key Hindrance to Market Growth
10.3.3 U.S.
10.3.3.1 Growth in Aki Prevalence
10.3.3.2 New Product Development to Boost the Demand for Crrt Products
10.3.3.3 Ongoing Clinical Trials to Prove the Safety And Efficacy of Crrt Products
10.3.3.4 Shortage of Registered Nurses in Icu Settings
10.3.4 Canada
10.3.4.1 Rising Aki Prevalence
10.3.4.2 High Cost of Crrt As Compared to Ihd
10.4 Asia-Pacific
10.4.1 Increasing Number of Sepsis Cases in India
10.4.2 Studies And Clinical Trials to Establish the Safety And Efficacy Profile of Crrt
10.4.3 Unfavorable Reimbursement Scenario
10.4.4 Japan
10.4.4.1 Increasing Use of Crrt for Non-Renal Indications
10.4.4.2 Well-Established Healthcare System
10.4.4.3 Large Number of Domestic Manufacturers—A Barrier to the Entry of Major Players
10.4.5 China
10.4.5.1 Rising Incidence of Aki And Esrd in China
10.4.5.2 Ongoing Research Studies
10.4.6 India
10.4.6.1 Rising Sepsis Cases in India
10.4.6.2 Increase in the Number of Dialysis Patients
10.4.6.3 Rising Number of Patients Admitted to Icus
10.4.6.4 Unfavorable Reimbursement Scenario
10.4.6.5 Lack of Randomized Trials And Dearth of Technical Expertise
10.4.6.6 Dearth of Indigenous Manufacturers for Crrt Products in India
10.4.7 Rest of Asia-Pacific
10.4.7.1 Taiwan, a Lucrative Market for Crrt Players
10.5 Rest of the World (Row)
10.5.1 Latin America And the Middle East
10.5.2 New Amendments Open Brazilian Healthcare Industry to Foreign Investment

11 Competitive Landscape
11.1 Introduction
11.1.1 Visionary Leaders
11.1.2 Innovators
11.1.3 Dynamic Differentiators
11.1.4 Emerging Companies
11.2 Strength of Product Portfolio
11.3 Business Strategy Excellence
11.4 Competitive Intensity
11.4.1 Evaluation Parameters And Scores
11.4.2 Scoring Methodology
11.4.3 Competitive Intensity Score, By Company
11.4.3.1 Baxter International Inc.
11.4.3.2 Fresenius Medical Care Ag & Co. Kgaa
11.4.3.3 Nikkiso Co., Ltd.
11.4.3.4 B. Braun Melsungen Ag
11.4.3.5 Nxstage Medical, Inc.
11.4.4 Competitive Intensity - Mapping of Baxter International Inc., Fresenius Medical Care Ag & Co. Kgaa, Nikkiso Co., Ltd., B. Braun Melsungen Ag, And Nxstage Medical, Inc.
*Top 25 Companies Analyzed for this Studies Are - Baxter International Inc.  (U.S.), Fresenius Medical Care Ag & Co. Kgaa  (Germany), Nxstage Medical, Inc. (U.S.), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen Ag (Germany), Asahi Kasei Corporation (Japan), Bellco S.R.L. (Italy), Toray Medical Co., Ltd. (Japan), Infomed Sa  (Switzerland), Medica S.P.A. (Italy), Medical Components, Inc. (U.S.), Medites Pharma Spol. S.R.O. (Czech Republic), Medtronic Plc (Ireland), Sws Hemodialysis Care Co., Ltd. (China), Ningbo Tianyi Medical Devices Co., Ltd (China), Cytosorbents Corporation (U.S.), Biomedica Spol. S R.O. (Czech Republic), Anjue Medical Equipment Co., Ltd. (China), Jiangxi Sanxin Medtec Co., Ltd. (China), Proxima Medicare (India), Nipro Corporation (Japan), Cytopherx, Inc. (U.S.), Dialysis Solutions Inc. (U.S.), Kimal Electronics Ltd (U.K.), Bl Lifesciences (India)

12 Company Profiles
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 Baxter International Inc.
12.2 Fresenius Medical Care Ag & Co. Kgaa
12.3 Nikkiso Co., Ltd.
12.4 Nxstage Medical, Inc.
12.5 B. Braun Melsungen Ag
12.6 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
12.7 Bellco S.R.L. (A Part of Medtronic Plc)
12.8 Toray Medical Co., Ltd.
12.9 Infomed Sa
12.10 Medica S.P.A.
12.11 Medical Components, Inc.
12.12 Medites Pharma Spol. S.R.O.
12.13 Medtronic Plc
12.14 Sws Hemodialysis Care Co. Ltd.
12.15 Ningbo Tianyi Medical Appliance Co., Ltd.
*Details On View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, And Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Subscription Portal
13.4 Introducing Rt: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details

List of Tables
Table 1 Average Selling Price of Crrt Machines, By Manufacturer, 2016 (USD)
Table 2 Average Selling Price of Crrt Bloodlines And Dialysate Bags, 2016 (USD)
Table 3 Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 4 Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Region, 2015-2022 (USD Million)
Table 5 Europe: Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Country, 2015-2022 (USD Million)
Table 6 North America: Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Country, 2015-2022 (USD Million)
Table 7 Asia-Pacific: Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Country, 2015-2022 (USD Million)
Table 8 Continuous Renal Replacement Therapy Disposables Market, By Type, 2015-2022 (USD Million)
Table 9 Continuous Renal Replacement Therapy Disposables Market, By Region, 2015-2022 (USD Million)
Table 10 Europe: Continuous Renal Replacement Therapy Disposables Market, By Country, 2015-2022 (USD Million)
Table 11 North America: Continuous Renal Replacement Therapy Disposables Market, By Country, 2015-2022 (USD Million)
Table 12 Asia-Pacific: Continuous Renal Replacement Therapy Disposables Market, By Country, 2015-2022 (USD Million)
Table 13 Continuous Renal Replacement Therapy Systems Market, By Region, 2015-2022 (USD Million)
Table 14 Europe: Continuous Renal Replacement Therapy Systems Market, By Country, 2015-2022 (USD Million)
Table 15 North America: Continuous Renal Replacement Therapy Systems Market, By Country, 2015-2022 (USD Million)
Table 16 Asia-Pacific: Continuous Renal Replacement Therapy Systems Market, By Country, 2015-2022 (USD Million)
Table 17 Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 18 Continuous Renal Replacement Therapy Market for Cvvh, By Region, 2015-2022 (USD Million)
Table 19 Europe: Continuous Renal Replacement Therapy Market for Cvvh, By Country, 2015-2022 (USD Million)
Table 20 North America: Continuous Renal Replacement Therapy Market for Cvvh, By Country, 2015-2022 (USD Million)
Table 21 Asia-Pacific: Continuous Renal Replacement Therapy Market for Cvvh, By Country, 2015-2022 (USD Million)
Table 22 Continuous Renal Replacement Therapy Market for Cvvhdf, By Region, 2015-2022 (USD Million)
Table 23 Europe: Continuous Renal Replacement Therapy Market for Cvvhdf, By Country, 2015-2022 (USD Million)
Table 24 North America: Continuous Renal Replacement Therapy Market for Cvvhdf, By Country, 2015-2022 (USD Million)
Table 25 Asia-Pacific: Continuous Renal Replacement Therapy Market for Cvvhdf, By Country, 2015-2022 (USD Million)
Table 26 Continuous Renal Replacement Therapy Market for Cvvhd, By Region, 2015-2022 (USD Million)
Table 27 Europe: Continuous Renal Replacement Therapy Market for Cvvhd, By Country, 2015-2022 (USD Million)
Table 28 North America: Continuous Renal Replacement Therapy Market for Cvvhd, By Country, 2015-2022 (USD Million)
Table 29 Asia-Pacific: Continuous Renal Replacement Therapy Market for Cvvhd, By Country, 2015-2022 (USD Million)
Table 30 Continuous Renal Replacement Therapy Market for Scuf, By Region, 2015-2022 (USD Million)
Table 31 Europe: Continuous Renal Replacement Therapy Market for Scuf, By Country, 2015-2022 (USD Million)
Table 32 North America: Continuous Renal Replacement Therapy Market for Scuf, By Country, 2015-2022 (USD Million)
Table 33 Asia-Pacific: Continuous Renal Replacement Therapy Market for Scuf, By Country, 2015-2022 (USD Million)
Table 34 Continuous Renal Replacement Therapy Market, By Region, 2015-2022 (USD Million)
Table 35 Europe: Continuous Renal Replacement Therapy Market, By Country, 2015-2022 (USD Million)
Table 36 Europe: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 37 Europe: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 38 Germany: Continuous Renal Replacement Therapy Market, By Product, 2013-2020 (USD Million)
Table 39 Germany: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 40 U.K.: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 41 U.K.: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 42 France: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 43 France: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 44 Roe: Continuous Renal Replacement Therapy Market Size, By Product, 2015-2022 (USD Million)
Table 45 Roe: Continuous Renal Replacement Therapy Market Size, By Modality, 2015-2022 (USD Million)
Table 46 North America: Continuous Renal Replacement Therapy Market, By Country, 2015-2022 (USD Million)
Table 47 North America: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 48 North America: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 49 U.S.: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 50 U.S.: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 51 Canada: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 52 Canada: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 53 Asia-Pacific: Continuous Renal Replacement Therapy Market, By Country, 2015-2022 (USD Million)
Table 54 Asia-Pacific: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 55 Asia-Pacific: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 56 Japan: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 57 Japan: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 58 China: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 59 China: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 60 India: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 61 India: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 62 Roapac: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 63 Roapac: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)
Table 64 Row: Continuous Renal Replacement Therapy Market, By Product, 2015-2022 (USD Million)
Table 65 Row: Continuous Renal Replacement Therapy Market, By Modality, 2015-2022 (USD Million)

List of Figures
Figure 1 Global Crrt Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
Figure 4 Crrt Market: Key Insights From Supply-Side Participants
Figure 5 Crrt Market: Key Insights From Demand–Side Participants
Figure 6 Estimation Of Crrt Procedural Volume
Figure 7 Research Methodology: Top-Down Approach [For Market Size Estimation Of Crrt Disposables (Bloodline Sets, Hemofilters, And Other Disposables)]
Figure 8 Research Methodology: Top-Down Approach (For Market Size Estimation Of Crrt Systems)
Figure 9 Research Methodology: Bottom-Up Approach (For Estimation Of Crrt Market Size)
Figure 10 Data Triangulation Steps (Top-Down And Bottom-Up Approaches)
Figure 11 Data Triangulation Methodology
Figure 12 Global Crrt Market By Product, 2017-2022 (USD Million)
Figure 13 Hemofilters Segment To Hold Largest Share Of Crrt Disposables Market In 2017 (USD Million)
Figure 14 Cvvhdf To Be The Fastest-Growing Crrt Modality During Forecast Period
Figure 15 Asia Pacific Crrt Market To Record Highest Growth During Forecast Period
Figure 16 Rising Prevalence Of Aki To Drive Global Crrt Market During Forecast Period
Figure 17 Dialysates & Replacement Fluids To Dominate Global Crrt Products Market During Forecast Period
Figure 18 Europe To Dominate Global Crrt Market Across All Modalities In 2017
Figure 19 Europe To Dominate Global Crrt Market During Forecast Period
Figure 20 Crrt Market: Drivers, Restraints, Opportunities, And Challenges
Figure 21 Global Incidence Of Aki Cases, 2010 Vs. 2015 Vs. 2020
Figure 22 Key Non-Renal Applications Of Crrt
Figure 23 Crrt-Associated Technical And Clinical Complications
Figure 24 Key Factors Affecting Reimbursement Rates For Crrt Procedures
Figure 25 Global Crrt Reimbursement Scenario (2016)
Figure 26 Medical Reimbursement Structure In Europe
Figure 27 Global Regulatory Bodies For Approval Of New Crrt Products
Figure 28 Porter’S Five Forces Analysis – Global Crrt Market
Figure 29 Design Recommendations For Crrt Machines
Figure 30 Utilization Of Crrt Vs Ihd And Sledd For Treatment Of Renal Patients In Icus, By Region (2016)
Figure 31 Number Of Crrt Patients Across The Globe, 2016
Figure 32 Global Crrt Market, By Product (2017 Vs. 2022)
Figure 33 Crrt Blood Purification Modalities
Figure 34 Global Crrt Market, By Modality (2017 Vs. 2022)
Figure 35 Europe To Dominate Global Crrt Market During Forecast Period (USD Million)
Figure 36 Europe: Crrt Market Snapshot
Figure 37 North America: Crrt Market Snapshot
Figure 38 Asia Pacific: Crrt Market Snapshot
Figure 39 Row: Crrt Market Snapshot
Figure 40 Competitive Leadership Mapping
Figure 41 Global Crrt Market Share, By Key Player (2016)
Figure 42 Scoring Methodology
Figure 43 Comparison Of Competitive Intensity Scores
Figure 44 Relative Positioning Of Companies Based On Competitive Intensity Score And Focus On Crrt
Figure 45 Baxter International Inc.: Company Snapshot (2016)
Figure 46 Fresenius Medical Care Ag & Co. Kgaa: Company Snapshot (2016)
Figure 47 Nikkiso Co., Ltd.: Company Snapshot (2015)
Figure 48 Nxstage Medical, Inc.: Company Snapshot (2016)
Figure 49 B. Braun Melsungen Ag: Company Snapshot (2016)
Figure 50 Asahi Kasei Corporation: Company Snapshot (2015)
Figure 51 Toray Industries, Inc.: Company Snapshot (2016)
Figure 52 Medtronic Plc.: Company Snapshot (2016)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Anjue Medical Equipment Co., Ltd. (China)
  • Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
  • B. Braun Melsungen Ag
  • Baxter International Inc.
  • Bellco S.R.L. (Italy)
  • Biomedica Spol. S R.O. (Czech Republic)
  • Bl Lifesciences (India)
  • Cytopherx, Inc. (U.S.)
  • Cytosorbents Corporation (U.S.)
  • Dialysis Solutions Inc. (U.S.)
  • Fresenius Medical Care Ag & Co. Kgaa
  • Infomed Sa
  • Jiangxi Sanxin Medtec Co., Ltd. (China)
  • Kimal Electronics Ltd (U.K.)
  • Medica S.P.A.
  • Medical Components, Inc.
  • Medites Pharma Spol. S.R.O.
  • Medtronic Plc
  • Nikkiso Co., Ltd.
  • Ningbo Tianyi Medical Appliance Co., Ltd.
  • Nipro Corporation (Japan)
  • Nxstage Medical, Inc.
  • Proxima Medicare (India)
  • Sws Hemodialysis Care Co. Ltd.
  • Toray Medical Co., Ltd.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll